Meet the Biosignals Team
Richard Rendell
Chief Executive Officer
Richard was covered in Forbes magazine where he highlighted his experience in modern precision medicine and explained that it’s now possible to tailor treatments for cancer, heart disease, stroke and other serious diseases by analysing what makes some patients respond better than others. Richard has worked with distinguished scientists and medical practitioners at the frontlines of healthcare. He believes a comprehensive approach to risk, prevention, diagnosis and treatment requires easy-to-use rapid deployment medical devices that can acquire key biometric data. When these data are coupled with molecular DNA data, we will significantly improve the outcomes of those with these diseases. Delivering these benefits requires intelligent software technology to interpret the clinical implications of these diverse information sources. Ultimately, patient outcomes will improve by predicting and preventing serious diseases, and ensuring the right treatments are available with a higher degree of confidence that the treatments are effective.
This potential impact on healthcare inspires and drives Richard’s deep personal commitment to deliver his vision through Biosignals Diagnostics. Richard draws on a unique set of skills and experience from 15 years of board and CEO roles with medical device and precision medicine companies. Prior to medical technology company involvement, Richard had a long executive career at Oracle Corporation with global responsibilities for products with $100M+ revenues. Richard also founded the advisory board for iSelect and was their CIO when listed on the ASX in June 2013.
Stephan Foy
Cardiologist & Non-executive Director
A graduate of University of Otago, Stephan gained his post-graduate Doctor of Medicine by research work at The Princess Margaret Hospital, Christchurch, NZ. After completing his Interventional Fellowship (Percutaneous Coronary Interventions) at Royal Perth Hospital, WA, Stephan was appointed as Consultant Cardiologist at Launceston General Hospital, Tasmania. Stephan’s expertise in invasive cardiac techniques led him to establish the invasive cardiac services at Launceston General Hospital. He implemented the hospital’s cardiac catheterisation and permanent pacemaker implantation services. Stephan had a leading role in the development and implementation of the Cardiac Services at St John of God Geelong Hospital. He has been a key advisor to the hospital’s Cardiac Catheterisation and Interventional Cardiology programmes and Cardiac Care Unit, culminating in his vital role in brokering the hospital’s Cardiac Surgery programme. Stephan’s professional affiliations include Fellow Royal Australasian College of Physicians and Fellow Cardiac Society of Australia and New Zealand. Stephan is an Adjunct Clinical Associate Professor at University of Notre Dame Australia and is an active clinical coordinator and tutor for the UNDA Melbourne Clinical School.
Lexie Qin
Chief Technology Officer
Lexie is a highly experienced Biomedical Engineer, covering the end-to-end process of developing medical devices that includes Intellectual Property strategy, regulatory strategy and commercialisation strategy. Lexie has a Bachelor of Biomedical Engineering, from Beijing University of Technology and a Master of Biomedical Engineering from University of Melbourne. Lexie is also a certified English – Chinese translator.
Lexie contributed to initial requirements, established development and manufacturing for the Biosignals Diagnostics ecgme device in China. Her language skills continue to drive Biosignals Diagnostics collaborations with PRC based technology businesses. Lexie is a key contributor to the design and development of our future flagship product (the advanced multi-function monitor).
Linda Lu
Business Development Manager
Linda Lu holds a Master of Biotechnology from the University of Melbourne with a strong foundation in pathology and molecular biology. She is passionate about bridging the gap between consumers and advanced healthcare by focusing on the commercialisation of innovative healthcare solutions for vulnerable populations and minority groups.
Before formally joining Biosignals Diagnostics, Linda successfully completed a year-long industry project with the company, supporting its efforts to enter the NDIS platform. Her dedication to innovation is evident in her active involvement in public speaking and educational initiatives through Toastmasters, as well as her volunteer work at the Royal Melbourne Hospital Aged Care Wards, where she was honoured as a finalist for the 2024 Volunteer Excellence Award.
Linda is excited to contribute her expertise to Biosignals Diagnostics, driving its mission to expand into the aged care sector and deliver impactful solutions to those who need them most.
Business Development Manager
Daniel Giannetti
Daniel is an enthusiastic biotechnology expert with a passion for delivering complex solutions and driving meaningful change within the life sciences sector. With a Bachelor's degree majoring in Biotechnology and currently undertaking a Master's degree at University of Melbourne, Daniel has cultivated a rich understanding of health science and a dedication for enhancing the lives of every individual through innovative biotechnology solutions.
Daniel's career spans diverse experiences from operations management, cardiac tissue engineering and the founding of a biotechnology startup. Beyond these pursuits, Daniel is an active volunteer for disability-focused initiatives that empower individuals with disabilities. His valuable experiences and unique insights in the disabilities sector will focus Biosignals Diagnostis's tailored support services.
Delivering a positive impact on healthcare requires diverse solutions that combine intelligence, innovation and creativity. Daniel's vision is to contribute meaningfully to these advancements and aid in delivering Biosignals Diagnostic's vision of empowering all individuals with transparent access and comprehensive interpretation of their biometric data.
Renee Ge
AI and Data Sciences Engineer
Renee is a competent young professional bringing 2 years of practical experience, in acquiring, interpreting and analysing data in a fast-paced environment to deliver complex data analysis outcomes including predictive modelling. Renee has extensive skills in AI languages such as Python and R with deep understanding of the application of machine learning in the clinical healthcare context. Renee is currently working on a major project at Monash University ”Monitoring health and wellbeing of seniors using unobstructive sensors” where she has developed computational models for the automatic continuous assessment of functional decline and onset of medical conditions. Renee is a certified English – Chinese translator.